Delivery Order SPE2DB22D2006-SPE2DB24FW0LU
- Not listed
- This federal contract award, with ID SPE2DB22D2006|SPE2DB24FV9UL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of sucralfate 1 gram tablets, with a ceiling value of $39,810.57 and a completion date of April 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, SPE2DB22D3301|SPE2DB25FY3RW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,782.12 firm fixed-price delivery order is for the supply of 4,568,000 Sucralfate 1 GM Tablet 90S, a medication used to treat peptic ulcers. The contract has an ultimate completion date of April 23, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,994.99, is for the delivery of Sucralfate 1 GM Tablets in 90-count bottles. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,215.64 firm fixed-price delivery order contract is for the supply of Sucralfate 1 GM tablets, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of October 31, 2023 and does not have a set-aside designation, indicating open competition....
- This federal contract award, identified as SPE2DB22D2006|SPE2DB24FW0YH, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,107.19, is for the delivery of Sucralfate 1 GM Tablet 90S, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,604.04, is a delivery order for the supply of Sucralfate 1 GM/10 ML Suspension for a period ending on December 31, 2024. The contract is a firm fixed-price agreement and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not reference...
- This federal contract award is a Delivery Order (SPE2DB23FU18T) issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4,561,367,996 milliliters of Sucralfate 1 gram per 10 milliliters suspension in 420 milliliter containers, with a ceiling value of $4,093.32. The contract has a firm fixed price and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
- This federal contract award, valued at $2,764.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. The contract has an ultimate completion date of September 26, 2023 and is a Firm Fixed Price Delivery Order contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,339.50, is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. The contract has an ultimate completion date of October 30, 2023 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award is a Delivery Order worth $2,320.37 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Sucralfate 1 GM Tablets in quantities of 90s. It is an open-competition contract with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a wide range...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FW0LUDelivery Order
This federal contract award, SPE2DB22D2006|SPE2DB24FW0LU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count bottles of 1 gram Sucralfate tablets, a medication used to treat ulcers. The contract has a firm fixed price, a ceiling value of $40,792.77, and an ultimate completion date of May 21, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.8k | 5/20/24 |